PNT — POINT Biopharma Global Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $1.33bn
- $998.03m
- $226.58m
U.S. STOCKS ON THE MOVE-Oddity Tech, Netflix, Warby Parker
Lantheus jumps as partner Point Biopharma agrees to Eli Lilly deal
Point Biopharma jumps on Lilly buyout deal
Point Biopharma jumps on Lilly buyout deal
U.S. STOCKS ON THE MOVE-Point Biopharma, Boeing, GM, McCormick & Co
Brief: Point Biopharma Says Upon Termination Of Agreement Under Specified Circumstances, Co May Be Required To Pay Lilly A Termination Fee Of About $54 Mln
Point Biopharma jumps on buyout deal by Lilly
Eli Lilly to buy cancer-focused Point Biopharma for $1.4 billion (updated)
Eli Lilly to buy Point Biopharma for $1.4 billion
Brief: Lilly To Acquire Point Biopharma
William Blair upbeat on Lantheus Holdings' radiopharmaceutical opportunity
Brief: Eckert & Ziegler Signs Agreement For The Supply Of Lutetium-177 With Point Biopharma
Point Biopharma Global Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: POINT Biopharma Q2 EPS USD -0.24
Brief: Point Biopharma Reports Second Quarter 2023 Financial Results And Provides Business Highlights
Point Biopharma Global Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Brief: ITM And POINT Biopharma Expand Global Supply Agreement For N.C.A. Lutetium-177
Brief: Point Biopharma And Advancell To Collaborate In The Development Of Lead-212-Labeled Radioligands
U.S. RESEARCH ROUNDUP-Amazon.com, Fedex, Nike